Guangzhou Wondfo Biotech Co.,Ltd (SHE:300482)
China
· Delayed Price · Currency is CNY 19.41
+0.10 (0.52%)
Mar 10, 2026, 2:14 PM CST
SHE:300482 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 8,970 | 10,709 | 13,338 | 14,088 | 17,522 | 30,571 | Upgrade
|
| Market Cap Growth | -18.39% | -19.71% | -5.32% | -19.60% | -42.68% | 72.31% | Upgrade
|
| Enterprise Value | 8,015 | 9,278 | 12,063 | 13,309 | 16,889 | 29,510 | Upgrade
|
| Last Close Price | 19.31 | 22.00 | 29.19 | 30.33 | 37.19 | 64.48 | Upgrade
|
| PE Ratio | 35.32 | 19.07 | 27.35 | 11.77 | 27.62 | 48.21 | Upgrade
|
| Forward PE | 35.43 | 14.64 | 21.86 | 12.49 | 19.74 | 40.75 | Upgrade
|
| PS Ratio | 3.49 | 3.49 | 4.82 | 2.48 | 5.21 | 10.88 | Upgrade
|
| PB Ratio | 1.61 | 1.90 | 2.89 | 3.11 | 5.00 | 10.21 | Upgrade
|
| P/TBV Ratio | 1.74 | 2.05 | 3.17 | 3.50 | 5.65 | 11.70 | Upgrade
|
| P/FCF Ratio | 956.76 | 246.19 | - | 12.82 | 84.06 | 47.59 | Upgrade
|
| P/OCF Ratio | 37.21 | 29.61 | 40.58 | 8.38 | 26.35 | 28.79 | Upgrade
|
| EV/Sales Ratio | 3.11 | 3.03 | 4.36 | 2.34 | 5.03 | 10.50 | Upgrade
|
| EV/EBITDA Ratio | 19.51 | 11.65 | 17.01 | 8.48 | 20.66 | 30.57 | Upgrade
|
| EV/EBIT Ratio | 37.13 | 15.72 | 26.41 | 10.05 | 26.61 | 35.75 | Upgrade
|
| EV/FCF Ratio | 854.89 | 213.29 | - | 12.11 | 81.03 | 45.94 | Upgrade
|
| Debt / Equity Ratio | 0.11 | 0.11 | 0.13 | 0.17 | 0.17 | 0.20 | Upgrade
|
| Debt / EBITDA Ratio | 1.45 | 0.74 | 0.82 | 0.48 | 0.69 | 0.63 | Upgrade
|
| Debt / FCF Ratio | 63.63 | 13.92 | - | 0.70 | 2.79 | 0.95 | Upgrade
|
| Net Debt / Equity Ratio | -0.18 | -0.28 | -0.34 | -0.34 | -0.28 | -0.30 | Upgrade
|
| Net Debt / EBITDA Ratio | -2.62 | -2.00 | -2.23 | -0.98 | -1.21 | -0.93 | Upgrade
|
| Net Debt / FCF Ratio | -108.27 | -36.60 | 15.20 | -1.39 | -4.74 | -1.40 | Upgrade
|
| Asset Turnover | 0.38 | 0.47 | 0.46 | 1.02 | 0.73 | 0.78 | Upgrade
|
| Inventory Turnover | 2.66 | 3.12 | 2.77 | 6.99 | 3.66 | 2.90 | Upgrade
|
| Quick Ratio | 6.59 | 4.11 | 5.86 | 2.55 | 2.70 | 2.33 | Upgrade
|
| Current Ratio | 7.78 | 4.61 | 6.68 | 2.94 | 3.27 | 2.86 | Upgrade
|
| Return on Equity (ROE) | 4.53% | 11.01% | 10.65% | 29.60% | 19.47% | 22.62% | Upgrade
|
| Return on Assets (ROA) | 2.01% | 5.71% | 4.73% | 14.84% | 8.66% | 14.23% | Upgrade
|
| Return on Invested Capital (ROIC) | 4.53% | 14.95% | 13.63% | 41.83% | 25.59% | 38.48% | Upgrade
|
| Return on Capital Employed (ROCE) | 3.50% | 9.30% | 8.60% | 25.70% | 15.60% | 23.50% | Upgrade
|
| Earnings Yield | 2.89% | 5.24% | 3.66% | 8.50% | 3.62% | 2.07% | Upgrade
|
| FCF Yield | 0.10% | 0.41% | -0.78% | 7.80% | 1.19% | 2.10% | Upgrade
|
| Dividend Yield | 2.06% | 1.82% | 1.37% | 1.65% | 0.81% | 0.60% | Upgrade
|
| Payout Ratio | 78.15% | 34.93% | 46.75% | 11.73% | 27.38% | 14.14% | Upgrade
|
| Buyback Yield / Dilution | -2.81% | -4.71% | -0.36% | 0.44% | -0.74% | 0.33% | Upgrade
|
| Total Shareholder Return | -0.75% | -2.89% | 1.01% | 2.09% | 0.07% | 0.93% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.